Pheniramine maleate inhibits CYP2D6, the specific P450-isozymes, to delay metabolic time and prolong antihistaminic effects.
Pheniramine maleate regulates cellular Ca transmembrane action, and inhibits Ca influx into BC3H-1 cells by inhibiting histamine with an IC50 value of 1.01 mM.
Pheniramine maleate (0.5, 1.0 mM; 24 h) induces cell apoptosis in human T-cell acute lymphoblastic leukemia cell lines.
Pheniramine maleate (1 μM-1 mM; 12-48 h) inhibits cell proliferation in a time-dependent manner and shows inhibitory concentration IC50s of 550 μM (CCRF-CEM cells) and 420 μM (Jurkat cells), respectively.
Medlife has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Viability Assay
Cell Line: |
Human T-cell acute lymphoblastic leukemia cell lines: CCRF-CEM and Jurkat ALL |
Concentration: |
0.5, 1.0 mM |
Incubation Time: |
24 hours |
Result: |
Induced cells apoptosis with chromatin condenses and marginalizes, and nuclear debris spreaded into the cytoplasm.
|
Cell Viability Assay
Cell Line: |
Human T-cell acute lymphoblastic leukemia cell lines: CCRF-CEM and Jurkat ALL |
Concentration: |
1 μM-1 mM |
Incubation Time: |
12, 24, 48 hours |
Result: |
Inhibited cell proliferation and survival in a time- and dose-dependent manner.
|